Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-18-004947
Filing Date
2018-03-08
Accepted
2018-03-08 16:31:45
Documents
91
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K chrs-10k_20171231.htm 10-K 4043325
2 EX-23.1 chrs-ex231_9.htm EX-23.1 2816
3 EX-31.1 chrs-ex311_6.htm EX-31.1 16648
4 EX-31.2 chrs-ex312_7.htm EX-31.2 16629
5 EX-32.1 chrs-ex321_8.htm EX-32.1 12153
6 GRAPHIC g2018030800331629346209.jpg GRAPHIC 29836
  Complete submission text file 0001564590-18-004947.txt   12509660

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT chrs-20171231.xml EX-101.INS 2488489
8 XBRL TAXONOMY EXTENSION SCHEMA chrs-20171231.xsd EX-101.SCH 79862
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE chrs-20171231_cal.xml EX-101.CAL 81855
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE chrs-20171231_def.xml EX-101.DEF 348113
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE chrs-20171231_lab.xml EX-101.LAB 647779
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE chrs-20171231_pre.xml EX-101.PRE 536946
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

EIN.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36721 | Film No.: 18676897
SIC: 2836 Biological Products, (No Diagnostic Substances)